The move comes after Anvisa was informed by Bharat Biotech that it’s Brazilian partner-Necessidade no longer has authorization to represent them in Brazil.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3BGC0ZN
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Brazil’s health regulator scraps Bharat Biotech’s EUA application of Covaxin
0 comments:
Post a Comment